Pharma & Biotech

Acadia Pharmaceuticals has encountered a significant obstacle for its European expansion strategy. Market uncertainty followed the announcement of a negative...

Six months after finalizing its acquisition, Merck KGaA is hitting significant milestones in its integration of SpringWorks Therapeutics. The operational...

Replimune Group Inc. is approaching a pivotal sequence of events that will shape its future. The biopharmaceutical company’s shares last...

ImmunityBio has entered February with significant operational momentum, driven by surging revenue, greater clarity from U.S. regulators, and initial international...

A key regulatory obstacle has been cleared for Sanofi's planned $2.2 billion purchase of Dynavax Technologies, moving the major pharmaceutical...

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic...

All eyes are on Danish pharmaceutical giant Novo Nordisk this week as it prepares to release its fourth-quarter 2025 financial...

Crinetics Pharmaceuticals has begun the year on a high note, with its first commercial product, PALSONIFY, delivering sales that exceeded...

Investor attention is turning to Bio-Rad Laboratories as the company prepares to release its fourth-quarter and full-year 2025 financial results....

All eyes are on pharmaceutical distribution giant Cencora this week as it prepares to release its first-quarter 2026 financial results....